SLC7A5 and colorectal cancer: Furthermore, JPH203, a small molecule inhibitor of LAT1, has shown significant pre-clinical efficacy in colorectal cancer and T-cell lymphoblastic lymphoma/leukemia and was well-tolerated in a Phase I study in patients with advanced solid tumors [170,171,172].